122 related articles for article (PubMed ID: 38416949)
1. Decreasing the Interval Wait Times for Screening Mammogram Results Using the "Reflex Testing" Algorithm.
Alvarenga J; Moran J; Bulgaru A; Moran MS
J Breast Imaging; 2022 Oct; 4(5):474-479. PubMed ID: 38416949
[TBL] [Abstract][Full Text] [Related]
2. Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 Breast Lesions.
Laws A; Crocker A; Dort J; Olson D; Elwi A; Anderes S; Parker S; Estey A; Keehn A; Quan ML
Ann Surg Oncol; 2019 Oct; 26(10):3361-3367. PubMed ID: 31342368
[TBL] [Abstract][Full Text] [Related]
3. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
[TBL] [Abstract][Full Text] [Related]
4. A comparative efficacy study of diagnostic digital breast tomosynthesis and digital mammography in BI-RADS 4 breast cancer diagnosis.
Ezeana CF; Puppala M; Wang L; Chang JC; Wong STC
Eur J Radiol; 2022 Aug; 153():110361. PubMed ID: 35617870
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population.
Palmieri FM; DePeri ER; Mincey BA; Smith JA; Wen LK; Chewar DM; Abaya R; Colon-Otero G; Perez EA
Mayo Clin Proc; 2009 Apr; 84(4):317-22. PubMed ID: 19339648
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Screening and BI-RADS Scoring Trends Before and During the COVID-19 Pandemic in an Academic Safety-Net Hospital.
Kobzeva-Herzog A; O'Shea T; Young S; Kenzik K; Zhao X; Slanetz P; Phillips J; Merrill A; Cassidy MR
Ann Surg Oncol; 2024 Apr; 31(4):2253-2260. PubMed ID: 38177460
[TBL] [Abstract][Full Text] [Related]
7. Racial Disparities in Breast Imaging Wait Times Before and After the Implementation of a Same-Day Biopsy Program.
Yoon SC; Taylor-Cho MW; Charles MG; Grimm L
J Breast Imaging; 2023 Mar; 5(2):159-166. PubMed ID: 38416937
[TBL] [Abstract][Full Text] [Related]
8. Tomosynthesis in the Diagnostic Setting: Changing Rates of BI-RADS Final Assessment over Time.
Raghu M; Durand MA; Andrejeva L; Goehler A; Michalski MH; Geisel JL; Hooley RJ; Horvath LJ; Butler R; Forman HP; Philpotts LE
Radiology; 2016 Oct; 281(1):54-61. PubMed ID: 27139264
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of probably benign (BI-RADS 3) lesions in mammography: what is the right follow-up protocol?
Buch KA; Qureshi MM; Carpentier B; Cunningham DA; Stone M; Jaffe C; Quinn M; Gonzalez C; LaVoye J; Hines N; Bloch BN
Breast J; 2015; 21(2):168-74. PubMed ID: 25669425
[TBL] [Abstract][Full Text] [Related]
10. Utilization and Cancer Yield of Probably Benign Assessment Category in the National Mammography Database: 2009 to 2018.
Elezaby MA; Mao L; Burnside ES; Zuley ML; Berg WA; Bhargavan-Chatfield M; Lee CS
J Am Coll Radiol; 2022 May; 19(5):604-614. PubMed ID: 35358482
[TBL] [Abstract][Full Text] [Related]
11. Recall rate of screening ultrasound with automated breast volumetric scanning (ABVS) in women with dense breasts: a first quarter experience.
Arleo EK; Saleh M; Ionescu D; Drotman M; Min RJ; Hentel K
Clin Imaging; 2014; 38(4):439-444. PubMed ID: 24768327
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk prediction and mammography biopsy decisions: a model-based study.
Armstrong K; Handorf EA; Chen J; Bristol Demeter MN
Am J Prev Med; 2013 Jan; 44(1):15-22. PubMed ID: 23253645
[TBL] [Abstract][Full Text] [Related]
13. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Yao MM; Joe BN; Sickles EA; Lee CS
Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
[TBL] [Abstract][Full Text] [Related]
14. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
[TBL] [Abstract][Full Text] [Related]
15. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the results of mammography screening in Dubrovnik-Neretva County in the 2006-2009 period].
Dzono-Boban A; Mratović MC; Masanović M
Acta Med Croatica; 2010 Dec; 64(5):453-9. PubMed ID: 21692270
[TBL] [Abstract][Full Text] [Related]
17. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
[TBL] [Abstract][Full Text] [Related]
18. Variability in Individual Radiologist BI-RADS 3 Usage at a Large Academic Center: What's the Cause and What Should We Do About It?
Ambinder EB; Mullen LA; Falomo E; Myers K; Hung J; Lee B; Harvey SC
Acad Radiol; 2019 Jul; 26(7):915-922. PubMed ID: 30268720
[TBL] [Abstract][Full Text] [Related]
19. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
